Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign up Log in
What is This Site Help Center Crisis
Powered By

Top 7 search results for "Inrebic" in Resources. To see all results and access other features, sign up for free.

Posts
Resources
Q&A
People
Groups
Treatments
What Is a JAK2 Mutation?
... Antimetabolites are cancer drugs that interfere with DNA by acting as a substitute for the normal building blocks of DNA.Fedratinib (Inrebic)Fedratinib (Inrebic) was approved in 2019 for treating three forms of myelofibrosis: high-risk, post-polycythemia vera, and post-essential thrombocythemia with splenomegaly (enlarged spleen). ...
What Is a JAK2 Mutation?
... Antimetabolites are cancer drugs that interfere with DNA by acting as a substitute for the normal building blocks of DNA.Fedratinib (Inrebic)Fedratinib (Inrebic) was approved in 2019 for treating three forms of myelofibrosis: high-risk, post-polycythemia vera, and post-essential thrombocythemia with splenomegaly (enlarged spleen). ...
What Is Cytoreductive Therapy in MPNs?
... Fedratinib, sold as Inrebic, is the most recent JAK inhibitor drug approved by the FDA for treating myelofibrosis.AnagrelideTaken in capsule form, anagrelide is the most specific form of cytoreductive treatment. It lowers platelet counts by reducing the production of megakaryocytes, the cells that go on to produce platelets. ...
What Is Cytoreductive Therapy in MPNs?
... Fedratinib, sold as Inrebic, is the most recent JAK inhibitor drug approved by the FDA for treating myelofibrosis.AnagrelideTaken in capsule form, anagrelide is the most specific form of cytoreductive treatment. It lowers platelet counts by reducing the production of megakaryocytes, the cells that go on to produce platelets. ...
Weakness and MPNs: Causes and Management
... Inrebic (fedratinib), a similar drug, was approved in 2019 by the U.S. Food and Drug Administration (FDA).Interferon drugs are a type of immunotherapy that work with the body’s immune system to get rid of extra blood cells. They include drugs like Intron A (interferon alfa-2b) and Pegasys (peginterferon alfa-2a). ...
Weakness and MPNs: Causes and Management
... Inrebic (fedratinib), a similar drug, was approved in 2019 by the U.S. Food and Drug Administration (FDA).Interferon drugs are a type of immunotherapy that work with the body’s immune system to get rid of extra blood cells. They include drugs like Intron A (interferon alfa-2b) and Pegasys (peginterferon alfa-2a). ...
How Polycythemia Vera Can Transform Into Myelofibrosis
... They include: Ruxolitinib (Jakafi) Fedratinib (Inrebic) Pacritinib (Vonjo) If you also have splenomegaly that doesn’t improve with any of the above treatments, you may need a splenectomy (surgery to remove your spleen), or you may need radiation therapy to reduce its size.A bone marrow transplant may be able to cure MF in some people. ...
How Polycythemia Vera Can Transform Into Myelofibrosis
... They include: Ruxolitinib (Jakafi) Fedratinib (Inrebic) Pacritinib (Vonjo) If you also have splenomegaly that doesn’t improve with any of the above treatments, you may need a splenectomy (surgery to remove your spleen), or you may need radiation therapy to reduce its size.A bone marrow transplant may be able to cure MF in some people. ...
6 Signs Your Myelofibrosis May Be Progressing
... Examples of these medications include: Ruxolitinib (Jakafi) Pacritinib (Vonjo) Fedratinib (Inrebic) “Watching and waiting” doesn’t mean doing nothing. ...
6 Signs Your Myelofibrosis May Be Progressing
... Examples of these medications include: Ruxolitinib (Jakafi) Pacritinib (Vonjo) Fedratinib (Inrebic) “Watching and waiting” doesn’t mean doing nothing. ...
Primary Myelofibrosis: Causes, Symptoms, and Treatments
... Inrebic (fedratinib) is another targeted therapy drug that can reduce PMF signs and symptoms. It is used to treat people with intermediate- or high-risk primary PMF, as well as people with secondary PMF. Stem Cell TransplantAlthough drug treatments may help keep PMF under control, they do not cure the disease. ...
Primary Myelofibrosis: Causes, Symptoms, and Treatments
... Inrebic (fedratinib) is another targeted therapy drug that can reduce PMF signs and symptoms. It is used to treat people with intermediate- or high-risk primary PMF, as well as people with secondary PMF. Stem Cell TransplantAlthough drug treatments may help keep PMF under control, they do not cure the disease. ...
7 Treatment Options for Myeloproliferative Neoplasms
... These medications can also help improve MPN symptoms and reduce the size of your spleen.JAK inhibitors approved to treat myelofibrosis include: Fedratinib (Inrebic) Momelotinib (Ojjaara) Pacritinib (Vonjo) Ruxolitinib (Jakafi) Tyrosine Kinase InhibitorsTKIs can be used to treat chronic myeloid leukemia. ...
7 Treatment Options for Myeloproliferative Neoplasms
... These medications can also help improve MPN symptoms and reduce the size of your spleen.JAK inhibitors approved to treat myelofibrosis include: Fedratinib (Inrebic) Momelotinib (Ojjaara) Pacritinib (Vonjo) Ruxolitinib (Jakafi) Tyrosine Kinase InhibitorsTKIs can be used to treat chronic myeloid leukemia. ...